(Q52845326)

8 May 2018

title

Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase. (English)

1 reference

8 May 2018

1 reference

Grob PM

1

1 reference

8 May 2018

Cao Y

2

1 reference

8 May 2018

Muchmore E

3

1 reference

8 May 2018

Ho DD

4

1 reference

8 May 2018

Norris S

5

1 reference

8 May 2018

Pav JW

6

1 reference

8 May 2018

Shih CK

7

1 reference

8 May 2018

Adams J

8

1 reference

8 May 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

8 May 2018

published in

Nature Medicine

1 reference

8 May 2018

volume

3

1 reference

8 May 2018

issue

6

1 reference

8 May 2018

page(s)

665-670

1 reference

8 May 2018

https://scigraph.springernature.com/pub.10.1038/nm0697-665

exact match

0 references

cites work

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group P

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

Pharmacokinetics of nevirapine: initial single-rising-dose study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

Prolonged CD4+ Lymphocytopenia and Thrombocytopenia in a Chimpanzee Persistently Infected with Human Immunodeficiency Virus Type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

Developing animal models for AIDS research--progress and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl)adenine against simian immunodeficiency virus infection in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

Long-term observations of human immunodeficiency virus-infected chimpanzees

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

Prevention of HIV infection by passive immunization with HIV immunoglobulin

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

Attempted prophylaxis of human immunodeficiency virus type 1 infection in chimpanzees with a nonnucleoside reverse transcriptase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

Transient increases in numbers of infectious cells in an HIV-infected chimpanzee following immune stimulation

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

Clinical Evaluation of Branched DNA Signal Amplification for Quantifying HIV Type 1 in Human Plasma

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-665

7 January 2021

Identifiers

DOI

10.1038/NM0697-665

1 reference

8 May 2018

1 reference

8 May 2018